Related Experiment Videos
Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction
J C Byon1, A B Kusari, J Kusari
1Department of Physiology, Tulane University Medical Center, New Orleans, LA 70112-2699, USA.
Abstract:
Insulin signaling involves a dynamic cascade of protein tyrosine phosphorylation and dephosphorylation. Most of our understanding of this process comes from studies focusing on tyrosine kinases, which are signal activators. Our knowledge of the role of protein-tyrosine phosphatases (PTPases), signal attenuators, in regulating insulin signal transduction remains rather limited. Protein-tyrosine phosphatase 1B (PTP-1B), the prototypical PTPase, is ubiquitously and abundantly expressed. Work from several laboratories, including our own, has implicated PTP-1B as a negative regulator of insulin action and as a potentially important mediator in the pathogenesis of insulin-resistance and non-insulin dependent diabetes mellitus (NIDDM).
Insights
Protein-tyrosine phosphatase 1B (PTP-1B) attenuates insulin signaling. This phosphatase is implicated in insulin resistance and non-insulin dependent diabetes mellitus (NIDDM).
Area of Science:
- Biochemistry
- Cellular signaling
- Endocrinology
Background:
- Insulin signaling is a complex cascade involving protein phosphorylation and dephosphorylation.
- Tyrosine kinases (activators) are well-studied, but protein-tyrosine phosphatases (PTPases, attenuators) roles are less understood.
- Protein-tyrosine phosphatase 1B (PTP-1B) is a key PTPase, widely expressed and involved in insulin signal regulation.
Purpose of the Study:
- To investigate the role of PTP-1B in insulin signal transduction.
- To understand PTP-1B's contribution to insulin resistance and NIDDM pathogenesis.
Main Methods:
- Studies focusing on tyrosine kinases and PTPases.
- Investigating PTP-1B's function in cellular signaling pathways.
- Analyzing PTP-1B's involvement in metabolic disease models.
Main Results:
- PTP-1B acts as a negative regulator of insulin action.
- PTP-1B is significantly implicated in the development of insulin resistance.
- PTP-1B plays a role in the pathogenesis of non-insulin dependent diabetes mellitus (NIDDM).
Conclusions:
- PTP-1B is a critical negative regulator of insulin signaling.
- Targeting PTP-1B may offer therapeutic strategies for insulin resistance and NIDDM.